The estimated Net Worth of Philip W Johnston is at least $830 Tausend dollars as of 13 November 2019. Mr. Johnston owns over 19,000 units of Conformis stock worth over $793,113 and over the last 8 years he sold CFMS stock worth over $37,050. In addition, he makes $0 as Independent Director at Conformis.
Philip has made over 1 trades of the Conformis stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 19,000 units of CFMS stock worth $37,050 on 13 November 2019.
The largest trade he's ever made was selling 19,000 units of Conformis stock on 13 November 2019 worth over $37,050. On average, Philip trades about 2,375 units every 0 days since 2017. As of 13 November 2019 he still owns at least 350,935 units of Conformis stock.
You can see the complete history of Mr. Johnston stock trades at the bottom of the page.
Philip W. Johnston serves as Independent Director of the Company. Mr. Johnston is the president and founder of Philip W. Johnston Associates, LLC, a communications and public affairs consulting firm. Prior to establishing his firm in 1996, Mr. Johnston served in senior positions in the Massachusetts legislature, the Massachusetts State cabinet, and the United States government. Mr. Johnston served five consecutive terms as an elected State Representative from the Fourth Plymouth District of Massachusetts. From 2000 to 2007, Mr. Johnston served as chair of the Massachusetts Democratic Party. From 1992 to 1996, Mr. Johnston served as the New England administrator of the U.S. Department of Health and Human Services. In 1991, Mr. Johnston served as the executive director of the Robert F. Kennedy Human Rights organization. In 1984, Mr. Johnston was appointed to serve as the Secretary of Health and Human Services in Massachusetts, administering 17 state agencies in the health and human services field. Since 1998, Mr. Johnston has served on the board of Directors of Blue Cross Blue Shield of Massachusetts. Since 2012, Mr. Johnston has served as the chair of the board of the Blue Cross Blue Shield of Massachusetts Foundation, which provides grants to Massachusetts nonprofit organizations that work in the healthcare field on behalf of low-income citizens. Since 2007, Mr. Johnston has served as a member of the board of trustees of the University of Massachusetts, and he chaired the search committee for a new Chancellor at the University of Massachusetts Medical School. Mr. Johnston is currently the vice chair of the University of Massachusetts Building Authority board of directors, and the vice chair of the University of Massachusetts Foundation.
Philip Johnston is 75, he's been the Independent Director of Conformis since 2017. There are 1 older and 13 younger executives at Conformis. The oldest executive at Conformis Inc. is Kenneth Fallon, 80, who is the Independent Chairman of the Board.
Philip's mailing address filed with the SEC is C/O CONFORMIS INC, 600 TECHNOLOGY PARK DRIVE, BILLERICA, MA, 01821.
Over the last 9 years, insiders at Conformis have traded over $10,769,806 worth of Conformis stock and bought 583,200 units worth $267,840 . The most active insiders traders include Capital Management Llcchris..., Philipp Lang und Mark A Augusti. On average, Conformis executives and independent directors trade stock every 21 days with the average trade being worth of $122,083. The most recent stock trade was executed by Mark A Augusti on 7 May 2022, trading 22,396 units of CFMS stock currently worth $10,302.
our mission patients vary in more ways than gender, race, and size. at conformis, we believe that optimizing implant fit and performance requires a patient-specific approach. our mission is to provide best-in-class, patient-specific implants and instrumentation that offer unique advantages over traditional orthopedic implants. we start with a simple idea: make the implant fit the patient rather than forcing the patient to fit the implant. our implants are individually sized and shaped to fit to each patient’s unique anatomy, providing precise anatomic fit and preserving healthy tissue. our disposable, patient-specific cutting and placement guides also eliminate many of the tools required for traditional orthopedic surgery and simplify surgical technique. by combining our personalized implants with our unique instrumentation, a surgeon is able to provide a custom solution that preserves more of a patient’s joint and minimizes surgical trauma. our company conformis, inc. is a privately h
Conformis executives and other stock owners filed with the SEC include: